Джиджи Ворган – В здравом уме и твердой памяти. Программа профилактики болезни Альцгеймера (страница 48)

Geng, J., et al. “Ginseng for cognition.” Cochrane Database Syst Rev 8 Dec 2010. 12:CD007769.

Small, G. W. “Alzheimer’s disease and other dementing disorders,” in Comprehensive Textbook of Psychiatry, 9th ed., B. J. and V. A. Sadock, eds. Williams & Wilkins (Baltimore: 2009), pp. 4058–65.

Petersen, R. C., et al. “Vitamin E and donepezil for the treatment of mild cognitive impairment.” N Engl J Med 352 (2005): 2379–88.

Schneider, L. S., et al. “Treatment with cholinesterase inhibitors and memantine of patients in the Alzheimer’s Disease Neuroimaging Initiative.” Arch Neurol 68 (2011): 58–66.

Silverman, D.H.S., et al. “Long-term effects of donepezil versus placebo on regional brain metabolism in minimally impaired subjects.” Alzheimer’s Association International Conference on Alzheimer’s Disease (ICAD), 2008.

Ferris, S., et al. “A double-blind, placebo-controlled trial of memantine in age-associated memory impairment (memantine in AAMI).” Int J Geriatr Psychiatry 22 (2007): 448–55.

Nixon, R. A., and D. S. Yang. “Autophagy failure in Alzheimer’s disease: locating the primary defect.” Neurobiol Dis 3 Feb 2011.

Nelson, L. D., et al. “PET of brain amyloid and tau in adults with Down syndrome.” Arch Neurol 68 (2001): 768–74.

Lu, P. H., et al. “Donepezil delays progression to AD in MCI subjects with depressive symptoms.” Neurology 72 (2009): 2115–21.

Mayberg, H. S. “Modulating dysfunctional limbic-cortical circuits in depression: Towards development of brain-based algorithms for diagnosis and optimised treatment.” Br Med Bull 65 (2003): 19–207.

Lally, P., et al. “How are habits formed: Modelling habit formation in the real world.” Eur J Soc Psychol 2010; 40: 998–1009.

Sarkisian, C. A., et al. “Pilot test of an attribution retraining intervention to raise walking levels in sedentary older adults.” J Am Geriatr Soc 55 (2007): 1842–46.

Lang, P. J., et al. “Emotion, motivation, and anxiety: Brain mechanisms and psychophysiology.” Biol Psychiatry 44 (1998): 1248–63.

Savine, A. C., and T. S. Braver. “Motivated cognitive control: reward incentives modulate preparatory neural activity during task-switching.” J Neurosci 30 (2010): 10, 294–305.

Dijkstra, K., et al. “Body posture facilitates retrieval of autobiographical memories.” Cognition 102 (2007): 139–49.

Ybarra, O., et al. “Mental exercising through simple socializing: social interaction promotes general cognitive functioning.” Pers Soc Psychol Bull 34 (2008): 248–59.

Sarkisian, C. A., et al. “Pilot test of an attribution retraining intervention to raise walking levels in sedentary older adults.” J Am Geriatr Soc 55 (2007): 1842–46.

Pope, S. K., et al. “Will a healthy lifestyle help prevent Alzheimer’s disease?” Ann Rev Public Health 42 (2003): 111–32.

Yang, K., et al. “Outcomes of health care providers’ recommendations for healthy lifestyle among U.S. adults with prediabetes.” Metab Syndr Relat Disord 9 (2011): 231-37.

Adams, C. E., and M. R. Leary. “Promoting self-compassionate attitudes toward eating among restrictive and guilty eaters.” J Soc Clin Psych 26 (2007): 1120–44.

Sol, B. G., et al. “The effect of self-efficacy on cardiovascular lifestyle.” Eur J Cardiovasc Nurs 29 Jul 2010.

http://www.sciencedirect.com/science/article/pii/S1474515110000812.

Yon, B. A., et al. “Personal digital assistants are comparable to traditional diaries for dietary self-monitoring during a weight loss program.”J Behav Med 30 (2007): 165–75.

Burke, L. E., et al. “Self-monitoring in weight loss: a systematic review of the literature.” J Am Diet Assoc 111 (2011): 92–102.

Honea, R. A., et al. “Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease.” Neurology 74 (2010): 113–20.

Mosconi, L., et al. “Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease.” Neurology 72 (2009): 513–20.

Frisardi, V., et al. “Aluminum in the diet and Alzheimer’s disease: from current epidemiology to possible disease-modifying treatment.” J Alzheimers Dis. 20 (2010): 17–30.

Rondeau, V., et al. “Aluminum and silica in drinking water and the risk of Alzheimer’s disease or cognitive decline: findings from 15-year follow-up of the PAQUID cohort.” Am J Epidemiol 169 (2009): 489–96.

Whitmer, R. A., et al. “Timing of hormone therapy and dementia: The critical window theory revisited.” Ann Neurol 69 (2011): 163–39.

Petersen, R. C., et al. “Vitamin E and donepezil for the treatment of mild cognitive impairment.” N Engl J Med 352 (2005): 2379–88.

Silverman, D.H.S., et al. “Long-term effects of donepezil versus placebo on regional brain metabolism in minimally impaired subjects.” Alzheimer’s Association International Conference on Alzheimer’s Disease, 2008.

Cataldo, J. K., et al. “Cigarette smoking is a risk factor for Alzheimer’s Disease: an analysis controlling for tobacco industry affiliation.” J Alzheimers Dis 19 (2010): 465–80.

Volkow, N. D., et al. “Effects of cell phone radiofrequency signal exposure on brain glucose metabolism.” JAMA 305 (2011): 808–13.

Arendash, G. W., T. Mori, et al. “Electromagnetic field treatment protects against and reverses cognitive impairment in Alzheimer’s disease mice.” J Alzheim Dis 19 (2010): 191–210.

Kamer, A. R., et al. “Inflammation and Alzheimer’s disease: Possible role of periodontal diseases.” Alzheim Dement 4 (2008): 242–50.

Bates, M. N. “Mercury amalgam dental fillings: an epidemiologic assessment.” Int J Hyg Environ Health 209 (2006): 309–16.

Yücel, M., et al. “Regional brain abnormalities associated with long-term heavy cannabis use.” Arch Gen Psychiatry 65 (2008): 694–701.

Scholes, K. E., and M. T. Martin-Iverson. “Cannabis use and neuropsychological performance in healthy individuals and patients with schizophrenia.” Psychol Med 40 (2010): 1635–46.

Morgan, C. J., et al. “Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study.” Br J Psychiatry 197 (2010): 285–90.

Lifshitz, V., et al. “Immunotherapy of cerebrovascular amyloidosis in a transgenic mouse model.” Neurobiol Aging 1 Mar 2011. http://www.sciencedirect.com/science/article/pii/S019745801100008X.

Bettermann, K., et al. “Statins, risk of dementia, and cognitive function: Secondary analysis of the Ginkgo Evaluation of Memory Study.” J Stroke Cerebrovasc Dis 12 Jan 2011. http://www.sciencedirect. com/science/article/pii/S1052305710002533

McGuinness B, et al. Statins for the treatment of dementia. Cochrane Database Syst Rev 14 Aug 2010 (8): CD007514.

Evans, M. A., and B. A. Golomb. “Statin-associated adverse cognitive effects: survey results from 171 patients.” Pharmacotherapy 29 (2009): 800–11.

Ruitenberg, A., et al. “Incidence of dementia: does gender make a difference?” Neurobiol Aging 22 (2001): 575–80.

Caccamo, A., et al. “Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments.” J Biol Chem 185 (2010): 13,107–20.

Kumar, V., and L. J. Kinsella. “Healthy brain aging: effect of head injury, alcohol and environmental toxins.” Clin Geriatr Med 26 (2010): 29–44.

Matser, E.J., et al. “Neuropsychological impairment in amateur soccer players.” JAMA282 (1999): 9071–3.

Voss, M. W., et al. “Plasticity of brain networks in a randomized intervention trial of exercise training in older adults.” Front Aging Neurosci 2 (2010): 1–17.

Gunsted, J., et al. “Improved memory function 12 weeks after bariatric surgery.” Surg Obes Rel Dis 30 Oct 2010.

Brinkworth, G. D., et al. “Long-term effects of a very low-carbohydrate diet and a low-fat diet on mood and cognitive function.” Arch Intern Med 169 (2009): 1873–80.